| Product Used For Unknown Indication |
35.1% |
| Drug Use For Unknown Indication |
13.0% |
| Hyperparathyroidism |
11.7% |
| Hyperphosphataemia |
11.7% |
| Anti-neutrophil Cytoplasmic Antibody Positive Vasculitis |
3.9% |
| Cardiac Failure |
3.9% |
| Blood Phosphorus Increased |
2.6% |
| Vitamin D Decreased |
2.6% |
| Bipolar I Disorder |
1.3% |
| Gastritis |
1.3% |
| Gastrooesophageal Reflux Disease |
1.3% |
| Hyperparathyroidism Secondary |
1.3% |
| Hyperparathyroidism Tertiary |
1.3% |
| Hypertension |
1.3% |
| Immunosuppressant Drug Therapy |
1.3% |
| Liver Transplant |
1.3% |
| Osteoporosis |
1.3% |
| Osteoporosis Postmenopausal |
1.3% |
| Pneumonia |
1.3% |
| Prophylaxis Against Transplant Rejection |
1.3% |
